Project description
Tissue viscoelasticity as a diagnostic biomarker of prostate cancer
Changes in mechanical properties such as viscoelasticity of biological soft tissues can be monitored using non-invasive imaging technology. Prostate cancer is characterised by higher stiffness compared to benign prostate tissue and that changes the propagation of shear waves. Funded by the Marie Skłodowska-Curie Actions programme, the IMPROVE project seeks to identify biomechanical biomarkers for prostate cancer diagnosis. Researchers will employ the transurethral shear wave viscoelastic elastography method to associate changes in the viscoelastic properties of the prostate with prostate cancer diagnosis features. They will produce a 3D anatomically realistic wave propagation model of the prostate and use AI for image reconstruction. Collectively, IMPROVE activities will pave the way for a novel approach to prostate cancer diagnosis.
Fields of science
Programme(s)
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Funding Scheme
MSCA-PF -
Coordinator
18071 Granada
Spain
See on map
Partners (1)
WC1E 6BT London
See on map